Wanbury Ltd. benchmarking: Perfomance to industry peers

Financial

	Wanbury	Sakar Healthcare	Fredun Pharma
Operational Metrics
Financials
5 yr Average ROE	-11.27 %	8.14 %	11.84 %
5yr average Equity Multiplier	-1.35	1.76	2.85
5yr Average Asset Turnover Ratio	1.54	0.45	1.08
5yr Avg Net Profit Margin	5.09 %	10.03 %	3.9 %
Price to Book	12.72	2.81	5.44
P/E	17.55	43.7	43.37
5yr Avg Cash Conversion Cycle	-103.0 Days	18.72 Days	175.29 Days
Inventory Days	21.96 Days	51.79 Days	146.68 Days
Days Receivable	61.39 Days	53.06 Days	142.46 Days
Days Payable	194.51 Days	115.64 Days	112.95 Days
5yr Average Interest Coverage Ratio	2.13	4.85	2.62
5yr Avg ROCE	-37.9 %	8.92 %	22.71 %
5yr Avg Operating Profit Margin	7.72 %	24.94 %	9.7 %
5 yr average Debt to Equity	0.2	0.49	0.93
5yr CAGR Net Profit	n/a	10.38 %	25.5 %
5yr Average Return on Assets	7.92 %	4.54 %	4.18 %
Shareholdings
Promoter Holding	43.07 %	52.86 %	43.06 %
Share Pledged by Promoters	62.18 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	3.23 %	-9.24 %	-7.28 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Wanbury	Sakar Healthcare	Fredun Pharma
Product Wise Break-Up	Product Wise Break-Up API`s & Formulation 100.0 Loan Licensing 0 Export 0 CDMO 0 Pharmaceuticals 0 0	Product Wise Break-Up CDMO 22.0 0 API`s & Formulation 0 Loan Licensing 5.0 Export 73.0 Pharmaceuticals 0	Product Wise Break-Up CDMO 0 Pharmaceutical 100.0 API`s & Formulation 0 Loan Licensing 0 Export 0 Pharmaceuticals 0
Segment Break-Up	Segment Break-Up Pharmaceuticals 100.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 30.27 International 0 Domestic 0 Rest of the World 0 Others 69.73	Location Wise Break-Up India 0 International 55.48 Domestic 44.52 Rest of the World 0	Location Wise Break-Up India 83.13 International 0 Domestic 0 Rest of the World 16.86 Others 0.01